Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1995 1
1996 7
1997 2
1998 2
1999 5
2000 8
2001 3
2002 6
2003 4
2004 6
2005 7
2006 6
2007 7
2008 3
2009 6
2010 11
2011 2
2012 5
2013 6
2014 6
2015 1
2016 4
2017 3
2018 2
2019 1
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 15668273

115 results

Results by year

Filters applied: . Clear all
Page 1
Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study.
Zervas K, Dimopoulos MA, Hatzicharissi E, Anagnostopoulos A, Papaioannou M, Mitsouli Ch, Panagiotidis P, Korantzis J, Tzilianos M, Maniatis A; Greek Myeloma Study Group. Zervas K, et al. Ann Oncol. 2004 Jan;15(1):134-8. doi: 10.1093/annonc/mdh026. Ann Oncol. 2004. PMID: 14679133 Free article. Clinical Trial.
Novel therapy in multiple myeloma.
Avilés A, Neri N, Nambo MJ, Cleto S, Castañeda C, González M, Talavera A, Huerta-Guzmán J. Avilés A, et al. Invest New Drugs. 2005 Oct;23(5):411-5. doi: 10.1007/s10637-005-2900-6. Invest New Drugs. 2005. PMID: 16133792 Clinical Trial.
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F, Oliva S, Petrucci MT, Conticello C, Catalano L, Corradini P, Siniscalchi A, Magarotto V, Pour L, Carella A, Malfitano A, Petrò D, Evangelista A, Spada S, Pescosta N, Omedè P, Campbell P, Liberati AM, Offidani M, Ria R, Pulini S, Patriarca F, Hajek R, Spencer A, Boccadoro M, Palumbo A. Gay F, et al. Lancet Oncol. 2015 Dec;16(16):1617-29. doi: 10.1016/S1470-2045(15)00389-7. Epub 2015 Nov 17. Lancet Oncol. 2015. PMID: 26596670 Free article. Clinical Trial.
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
Vogl DT, Liu SV, Chong EA, Luger SM, Porter DL, Schuster SJ, Tsai DE, Perl A, Loren AW, Goldstein SC, Nasta SD, Andreadis C, Mangan PA, Hummel K, Siegel DL, Glatstein E, Stadtmauer EA. Vogl DT, et al. Am J Hematol. 2007 Dec;82(12):1071-5. doi: 10.1002/ajh.21038. Am J Hematol. 2007. PMID: 17696204 Free article.
115 results